Janux Therapeutics Inc.

NASDAQ: JANX · Real-Time Price · USD
24.75
-0.38 (-1.51%)
At close: Jun 05, 2025, 3:59 PM
24.76
0.04%
After-hours: Jun 05, 2025, 04:31 PM EDT

Janux Therapeutics Revenue

Janux Therapeutics reported an annual revenue of $10.59M, reflecting a 30.99% growth. For the quarter ending March 31, 2025, Janux Therapeutics generated $0 in revenue.
Revenue (ttm)
$10.59M
Revenue Growth
30.99%
Price / Sales Ratio
271.8
Revenue / Employee
$116.35K
Employees
91
Market Cap
1.46B

Revenue Chart

Revenue History

Fiscal Year End Revenue % Change
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.